DavidRosenberg wrote: It will be challenging ot restore the company form it's previous glory days of septemeber 2018 during the cannabis bubble.
FSD Pharma was always biotech.
Biotech stocks are extremely speculative and high risk.
They need to show their drugs work , and have strong intellectual patents that cross USA and Eurozone.
Lucid MS worked in animal mouse models.
Lucid Psych is not yet patented from my understanding and was discovered by kotra's team at UHN using Aritificial intelligence? Which is a psychedelic/psycoactive molecule which targets the brain we wont know more about that until they patent it in my opinion so no other company can copy them.
FSD PEA needs a new phase 2 indication? $ELYM is a competing company
Eliem Therapeutics - Optimizing Treatments for Neurological Disorders (eliemtx.com) Stock is all time lows , is it on a discount? I dont know ask your financial advisor
I have personally averaged down enough time now and am content with my holdings and now am waiting for updates
hope this year they can start trials in a professional manner thats different from previous management which did not update us on any covid 19 trial results ....
Cheers !